Literature DB >> 24514875

Association between the CYP1A2-164 A/C polymorphism and colorectal cancer susceptibility: a meta-analysis.

Jianbing Hu1, Chuan Liu, Qinghua Yin, Mingzhen Ying, Junhui Li, Lian Li, Chun-xia Zhou, Yajie Wang.   

Abstract

To date, epidemiological studies have assessed the association between CYP1A2-164 A/C polymorphism and colorectal cancer susceptibility. However, the results of these studies remained controversial. We aimed to examine the associations by conducting a meta-analysis of case-control studies. A total of 11 studies including 5,093 cases and 5,941 controls evaluated the association between the CYP1A2-164 A/C polymorphism and colorectal cancer susceptibility. No significantly associations were found in all genetic models (CC vs. AA: OR = 1.14, 95 % CI = 0.93-1.40; AC vs. AA: OR = 1.05, 95 % CI = 0.91-1.20; dominant model: OR = 1.08, 95 % CI = 0.95-1.24; recessive model: OR = 1.10, 95 % CI = 0.95-1.28). In the subgroup analysis by ethnicity or source of controls, there were still no significant associations detected in all genetic models. This meta-analysis suggested the CYP1A2-164 A/C polymorphism was not a risk factor for increasing colorectal cancer, further large and well-designed studies are needed to confirm these conclusions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24514875     DOI: 10.1007/s00438-013-0806-0

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  29 in total

1.  Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: a meta-analysis.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos; Souzana Choussein; Nikos F Vlahos
Journal:  Int J Gynecol Cancer       Date:  2011-02       Impact factor: 3.437

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 3.  Polymorphisms in DNA repair genes and associations with cancer risk.

Authors:  Ellen L Goode; Cornelia M Ulrich; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

Review 6.  The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis.

Authors:  Daniel W Nebert; Timothy P Dalton
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

7.  Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.

Authors:  H Yamazaki; P M Shaw; F P Guengerich; T Shimada
Journal:  Chem Res Toxicol       Date:  1998-06       Impact factor: 3.739

8.  Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.

Authors:  István Kiss; Zsuzsa Orsós; Katalin Gombos; Barna Bogner; András Csejtei; Antal Tibold; Zsuzsa Varga; Emese Pázsit; Ingrid Magda; Annamária Zölyomi; István Ember
Journal:  Anticancer Res       Date:  2007 Jul-Aug       Impact factor: 2.480

9.  CYP1A2 164 A-->C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas.

Authors:  Mona Saebø; Camilla F Skjelbred; Karin Brekke Li; Inger Marie Bowitz Lothe; Per Chr Hagen; Egil Johnsen; Kjell M Tveit; Elin H Kure
Journal:  Anticancer Res       Date:  2008 Jul-Aug       Impact factor: 2.480

Review 10.  Assessment of cumulative evidence on genetic associations: interim guidelines.

Authors:  John P A Ioannidis; Paolo Boffetta; Julian Little; Thomas R O'Brien; Andre G Uitterlinden; Paolo Vineis; David J Balding; Anand Chokkalingam; Siobhan M Dolan; W Dana Flanders; Julian P T Higgins; Mark I McCarthy; David H McDermott; Grier P Page; Timothy R Rebbeck; Daniela Seminara; Muin J Khoury
Journal:  Int J Epidemiol       Date:  2007-09-26       Impact factor: 7.196

View more
  5 in total

1.  The expression and clinical significance of microRNAs in colorectal cancer detecting.

Authors:  Xiaoyu Yang; Jiateng Zhong; Yinghua Ji; Jinsong Li; Yu Jian; Jinghang Zhang; Wancai Yang
Journal:  Tumour Biol       Date:  2014-12-06

2.  Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.

Authors:  Tao Li; Haohai Huang; Dan Liao; Huahuang Ling; Bingguang Su; Maode Cai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

3.  Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses.

Authors:  Vladimir Vukovic; Carolina Ianuale; Emanuele Leoncini; Roberta Pastorino; Maria Rosaria Gualano; Rosarita Amore; Stefania Boccia
Journal:  BMC Cancer       Date:  2016-02-10       Impact factor: 4.430

4.  Interleukin-10 rs1800896 polymorphism is associated with increased head and neck cancer risk but not associated with its clinical stages.

Authors:  Wei Huang; Juan Song; Xiao-Wei Jia; Yin-Xue Chen; Jia Shi; Xun Jiang
Journal:  Oncotarget       Date:  2017-06-06

5.  Genetic variation in the HLA-G 3'UTR 14-bp insertion/deletion and the associated cancer risk: evidence from 25 case-control studies.

Authors:  You Jiang; Jun Lu; Yue-E Wu; Xin Zhao; Liang Li
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.